• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于荟萃分析的模型用于评估严重发热伴血小板减少综合征患者的不良预后。

A model based on meta-analysis to evaluate poor prognosis of patients with severe fever with thrombocytopenia syndrome.

作者信息

Liu Zishuai, Jiang Zhouling, Zhang Ligang, Xue Xiaoyu, Zhao Chenxi, Xu Yanli, Zhang Wei, Lin Ling, Chen Zhihai

机构信息

Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Department of Infectious Diseases, Yantai Qishan Hospital, Yantai, China.

出版信息

Front Microbiol. 2024 Jan 8;14:1307960. doi: 10.3389/fmicb.2023.1307960. eCollection 2023.

DOI:10.3389/fmicb.2023.1307960
PMID:38260897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10801726/
Abstract

BACKGROUND

Early identification of risk factors associated with poor prognosis in Severe fever with thrombocytopenia syndrome (SFTS) patients is crucial to improving patient survival.

METHOD

Retrieve literature related to fatal risk factors in SFTS patients in the database, extract the risk factors and corresponding RRs and 95% CIs, and merge them. Statistically significant factors were included in the model, and stratified and assigned a corresponding score. Finally, a validation cohort from Yantai Qishan Hospital in 2021 was used to verify its predictive ability.

RESULT

A total of 24 articles were included in the meta-analysis. The model includes six risk factors: age, hemorrhagic manifestations, encephalopathy, Scr and BUN. The analysis of lasso regression and multivariate logistic regression shows that model score is an independent risk factor (OR = 1.032, 95% CI 1.002-1.063,  = 0.034). The model had an area under the curve (AUC) of 0.779 (95% CI 0.669-0.889, <0.001). The validation cohort was divided into four risk groups with cut-off values. Compared with the low-medium risk group, the mortality rate of high-risk and very high-risk patients was more significant (RR =5.677, 95% CI 4.961-6.496, <0.001).

CONCLUSION

The prediction model for the fatal outcome of SFTS patients has shown positive outcomes.https://www.crd.york.ac.uk/prospero/ (CRD42023453157).

摘要

背景

早期识别与严重发热伴血小板减少综合征(SFTS)患者预后不良相关的危险因素对于提高患者生存率至关重要。

方法

检索数据库中与SFTS患者死亡危险因素相关的文献,提取危险因素及相应的RRs和95% CIs,并进行合并。将具有统计学意义的因素纳入模型,并进行分层和赋予相应分数。最后,使用烟台奇山医院2021年的验证队列来验证其预测能力。

结果

荟萃分析共纳入24篇文章。该模型包括六个危险因素:年龄、出血表现、脑病、Scr和BUN。套索回归和多变量逻辑回归分析表明,模型评分是一个独立危险因素(OR = 1.032,95% CI 1.002 - 1.063,P = 0.034)。该模型的曲线下面积(AUC)为0.779(95% CI 0.669 - 0.889,P < 0.001)。验证队列根据截断值分为四个风险组。与低 - 中风险组相比,高风险和极高风险患者的死亡率更高(RR = 5.677,95% CI 4.961 - 6.496,P < 0.001)。

结论

SFTS患者死亡结局的预测模型已显示出阳性结果。https://www.crd.york.ac.uk/prospero/(CRD42023453157)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/5e6eeb84c8b1/fmicb-14-1307960-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/43754c8420b1/fmicb-14-1307960-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/d82147e51029/fmicb-14-1307960-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/db6399f83375/fmicb-14-1307960-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/5e6eeb84c8b1/fmicb-14-1307960-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/43754c8420b1/fmicb-14-1307960-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/d82147e51029/fmicb-14-1307960-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/db6399f83375/fmicb-14-1307960-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a60/10801726/5e6eeb84c8b1/fmicb-14-1307960-g004.jpg

相似文献

1
A model based on meta-analysis to evaluate poor prognosis of patients with severe fever with thrombocytopenia syndrome.基于荟萃分析的模型用于评估严重发热伴血小板减少综合征患者的不良预后。
Front Microbiol. 2024 Jan 8;14:1307960. doi: 10.3389/fmicb.2023.1307960. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Novel nomograms to predict risk and prognosis in hospitalized patients with severe fever with thrombocytopenia syndrome.预测发热伴血小板减少综合征住院患者风险和预后的新型列线图
Front Med (Lausanne). 2023 Dec 1;10:1321490. doi: 10.3389/fmed.2023.1321490. eCollection 2023.
4
Risk factors of severe fever with thrombocytopenia syndrome combined with central neurological complications: A five-year retrospective case-control study.发热伴血小板减少综合征合并中枢神经系统并发症的危险因素:一项五年回顾性病例对照研究。
Front Microbiol. 2022 Nov 3;13:1033946. doi: 10.3389/fmicb.2022.1033946. eCollection 2022.
5
Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with SFTS.SFTS 住院患者发生危重症的临床风险评分的制定与验证。
J Infect Public Health. 2023 Mar;16(3):393-398. doi: 10.1016/j.jiph.2023.01.007. Epub 2023 Jan 16.
6
Eosinophils and basophils in severe fever with thrombocytopenia syndrome patients: Risk factors for predicting the prognosis on admission.严重发热伴血小板减少综合征患者的嗜酸性粒细胞和嗜碱性粒细胞:入院时预测预后的危险因素。
PLoS Negl Trop Dis. 2022 Dec 21;16(12):e0010967. doi: 10.1371/journal.pntd.0010967. eCollection 2022 Dec.
7
Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes.严重发热伴血小板减少综合征:流行病学、临床特征、常规实验室诊断、危险因素和结局的系统评价和荟萃分析。
BMC Infect Dis. 2020 Aug 5;20(1):575. doi: 10.1186/s12879-020-05303-0.
8
Early-Warning Immune Predictors for Invasive Pulmonary Aspergillosis in Severe Patients With Severe Fever With Thrombocytopenia Syndrome.严重发热伴血小板减少综合征重症患者侵袭性肺曲霉病的预警免疫预测因子。
Front Immunol. 2021 May 7;12:576640. doi: 10.3389/fimmu.2021.576640. eCollection 2021.
9
The value of cystatin C in evaluating the severity and prognosis of patients with severe fever with thrombocytopenia syndrome.胱抑素 C 在评估重症发热伴血小板减少综合征患者病情严重程度及预后中的价值。
BMC Infect Dis. 2022 Apr 9;22(1):357. doi: 10.1186/s12879-022-07320-7.
10
Score risk model for predicting severe fever with thrombocytopenia syndrome mortality.预测发热伴血小板减少综合征死亡率的评分风险模型。
BMC Infect Dis. 2017 Jan 7;17(1):42. doi: 10.1186/s12879-016-2111-0.

引用本文的文献

1
Prediction of Mortality by Clinical Laboratory Parameters in Severe Fever with Thrombocytopenia Syndrome: A Meta-Analysis.通过临床实验室参数预测发热伴血小板减少综合征患者的死亡率:一项Meta分析
Trop Med Infect Dis. 2025 Jul 9;10(7):193. doi: 10.3390/tropicalmed10070193.
2
Severe fever thrombocytopenia syndrome proceeding east.严重发热伴血小板减少综合征正在向东蔓延。
J Rural Med. 2025 Jul;20(3):253-254. doi: 10.2185/jrm.2025-011. Epub 2025 Jul 1.
3
Retrospective Analysis of Severe Fever With Thrombocytopenia Syndrome and Construction of a Nomogram Prediction Model for Mortality Risk Factors.

本文引用的文献

1
Clinical features of severe fever with thrombocytopenia syndrome and analysis of risk factors for mortality.严重发热伴血小板减少综合征的临床特征及死亡危险因素分析。
BMC Infect Dis. 2021 Dec 14;21(1):1253. doi: 10.1186/s12879-021-06946-3.
2
Single-cell landscape of peripheral immune responses to fatal SFTS.外周免疫对致命性发热伴血小板减少综合征病毒反应的单细胞全景图。
Cell Rep. 2021 Nov 23;37(8):110039. doi: 10.1016/j.celrep.2021.110039.
3
Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome.
发热伴血小板减少综合征回顾性分析及死亡危险因素列线图预测模型构建
Open Forum Infect Dis. 2025 Jun 2;12(7):ofaf318. doi: 10.1093/ofid/ofaf318. eCollection 2025 Jul.
4
Metabolic Profiling Reveals Potential Prognostic Biomarkers for SFTS: Insights into Disease Severity and Clinical Outcomes.代谢谱分析揭示了严重发热伴血小板减少综合征潜在的预后生物标志物:对疾病严重程度和临床结局的见解。
Metabolites. 2025 Mar 27;15(4):228. doi: 10.3390/metabo15040228.
5
A multicenter study on developing a prognostic model for severe fever with thrombocytopenia syndrome using machine learning.一项利用机器学习开发严重发热伴血小板减少综合征预后模型的多中心研究。
Front Microbiol. 2025 Mar 19;16:1557922. doi: 10.3389/fmicb.2025.1557922. eCollection 2025.
6
Aspartate aminotransferase to platelet ratio correlates with poor prognosis and metabolic alterations in infection.天冬氨酸转氨酶与血小板比值与感染患者的不良预后及代谢改变相关。
Front Immunol. 2025 Jan 17;15:1471511. doi: 10.3389/fimmu.2024.1471511. eCollection 2024.
7
Machine learning for identifying risk of death in patients with severe fever with thrombocytopenia syndrome.用于识别严重发热伴血小板减少综合征患者死亡风险的机器学习
Front Microbiol. 2024 Sep 13;15:1458670. doi: 10.3389/fmicb.2024.1458670. eCollection 2024.
法维拉韦治疗发热伴血小板减少综合征患者的临床疗效及安全性评价。
EBioMedicine. 2021 Oct;72:103591. doi: 10.1016/j.ebiom.2021.103591. Epub 2021 Sep 23.
4
Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome.T-705 治疗发热伴血小板减少综合征的临床疗效及抗病毒机制。
Signal Transduct Target Ther. 2021 Apr 16;6(1):145. doi: 10.1038/s41392-021-00541-3.
5
A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.一项多中心非随机、非对照、单臂临床试验,评估使用法匹拉韦治疗伴有发热伴血小板减少综合征的患者的疗效和安全性。
PLoS Negl Trop Dis. 2021 Feb 22;15(2):e0009103. doi: 10.1371/journal.pntd.0009103. eCollection 2021 Feb.
6
Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus.发热伴血小板减少综合征病毒:一种高致死性布尼亚病毒。
Crit Rev Microbiol. 2021 Feb;47(1):112-125. doi: 10.1080/1040841X.2020.1847037. Epub 2020 Nov 27.
7
Direct Transmission of Severe Fever with Thrombocytopenia Syndrome Virus from Domestic Cat to Veterinary Personnel.家猫至兽医人员中严重发热伴血小板减少综合征病毒的直接传播。
Emerg Infect Dis. 2020 Dec;26(12):2994-2998. doi: 10.3201/eid2612.191513.
8
Epidemiology and Ecology of Severe Fever With Thrombocytopenia Syndrome in China, 2010‒2018.中国 2010-2018 年严重发热伴血小板减少综合征的流行病学和生态学研究。
Clin Infect Dis. 2021 Dec 6;73(11):e3851-e3858. doi: 10.1093/cid/ciaa1561.
9
Severe fever with thrombocytopenia syndrome in Hefei: Clinical features, risk factors, and ribavirin therapeutic efficacy.合肥市严重发热伴血小板减少综合征:临床特征、危险因素和利巴韦林治疗效果。
J Med Virol. 2021 Jun;93(6):3516-3523. doi: 10.1002/jmv.26544. Epub 2020 Oct 8.
10
Clinical manifestations of death with severe fever and thrombocytopenia syndrome: A meta-analysis and systematic review.严重发热伴血小板减少综合征死亡的临床表现:Meta 分析和系统评价。
J Med Virol. 2021 Jun;93(6):3960-3968. doi: 10.1002/jmv.26518. Epub 2020 Sep 30.